Executive Director, Global Medical Strategy Head - Gastrointestinal Cancers

$270,000 - $320,000/Yr

Revolution Medicines - Redwood City, CA

Full-time - Executive

Redwood City, CA

Professional, Scientific, and Technical Services

About the position

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The Executive Director, Global Medical Strategy Head (GMSH) for Gastrointestinal (GI) Cancers is a pivotal role within the Medical Affairs leadership team. This individual will be responsible for developing and executing the Global Medical Affairs (GMA) strategy and tactical plans, emphasizing launch readiness and life cycle management for medicines across the current and future GI cancer portfolio. The successful candidate will have a proven track record of developing and driving medical strategy for multiple assets, effectively communicating key scientific data through publications, medical information, medical communications, and congress activities, as well as gathering insights through Advisory Boards and Key Opinion Leader (KOL) engagements. The GMSH will lead the development and execution of the multi-year global and US medical strategy for GI cancers, including oversight of the publication and medical communications strategy, integrated evidence planning, lifecycle management, and budget and headcount planning processes. This individual will be responsible for building and leading a GI cancer strategy team and will be expected to lead the Global Medical Affairs Team (GMAT) to execute medical strategies, contribute to the operations and oversight of medical activities associated with GI cancers, and work cross-functionally to support associated pre-launch activities. Regular updates and support to senior leadership will also be a key aspect of this role. The ideal candidate is a skilled and collaborative leader, highly effective communicator, entrepreneurial, detail-oriented, proactive, and scientifically driven. They will serve as a member of the Global Medical Leadership Team, contributing to overall medical portfolio management and prioritization, as well as the development of the multi-year GMA strategic plan. The GMSH will lead the GI cancer team in the development and execution of the GMA strategy and medical objectives for the GI cancer franchise, including activities related to scientific engagement and communication, evidence generation, internal education, and patient advocacy. This role requires a strong scientific background in GI cancers, excellent networking skills, and the ability to thrive in a fast-paced, dynamic environment.

Responsibilities

• Develop and execute the Global Medical Affairs (GMA) strategy and tactical plans for GI cancers.
• Lead the development and execution of the multi-year global and US medical strategy for GI cancers.
• Oversee the publication and medical communications strategy, integrated evidence planning, lifecycle management, and budget and headcount planning processes.
• Build and lead a GI cancer strategy team.
• Lead the Global Medical Affairs Team (GMAT) to execute medical strategies and contribute to the operations and oversight of medical activities associated with GI cancers.
• Work collaboratively with cross-functional counterparts in Development, Research, and Commercial to design and implement a comprehensive strategy across all GI cancer indications.
• Communicate clinical and scientific data to physicians and other healthcare professionals through presentations, educational programs, and scientific discussions.
• Support competitive intelligence team activities through landscape assessments and development of patient journey insights.
• Manage budgets and resources efficiently for GMA supported activities in GI cancer.

Requirements

• An advanced doctorate degree (PharmD, PhD, MD, DO or equivalent) in medical/scientific area is required.
• 10 years minimum experience in academic medicine, biotech and/or pharmaceutical industry, with at least five years of experience in oncology research and/or patient care.
• Strong scientific background in GI cancers with a good understanding of biomarker-driven disease.
• Strong networking skills with deep existing relationships with GI cancer healthcare professionals including global top key opinion leaders.
• Experience in KOL mapping and development of engagement plans.
• Previous overall responsibility and accountability for medical affairs activities, including budget management for more than one compound.
• Direct, hands-on experience executing the activities of various functions within medical affairs (training, medical communications, medical information, EAP, Evidence Generation, publications).
• Extensive experience in global product launches including support of integrated brand plan ideation, regulatory submissions, reimbursement, and label development.
• Proven track record of clinical trial support including protocol development/review, site selection support, enrollment support, and data analysis.

Nice-to-haves

• MD degree is preferred.
• Experience in guideline submissions (e.g. NCCN) and engagements with global health authorities preferred.

Benefits

• Employee assistance program